Merck KGaA Lifts FY26 Outlook, Backs Positive Mid-term View, Despite Weak Q1; Stock Gains

Merck KGaA lifted its fiscal 2026 guidance and maintained its mid-term view, helping shares rise about 8% in German trading despite weak first-quarter results. The update signals improved outlook confidence even as near-term earnings remain soft. The move is likely to be stock-specific rather than sector-wide.

Analysis

Merck KGaA lifted its fiscal 2026 guidance and maintained its mid-term view, helping shares rise about 8% in German trading despite weak first-quarter results. The update signals improved outlook confidence even as near-term earnings remain soft. The move is likely to be stock-specific rather than sector-wide.